Originally posted by Dlfg1234:
↑
Yes I agree, we need to take it one step at a time. I just thought that it would be good to highlight future risks with scaling manufacturing from clinical trial supplies to commercial supply.
Expand
Scorpion Venom Used to Direct T Cells to Target Brain Cancer Tumors (scitechdaily.com)VIDEO VIDEO "The new treatment, a called , was approved for patients with mantle cell lymphoma that does not respond to other treatments or has .
Mantle cell lymphoma arises in , a type of white blood cell. Most people with mantle cell lymphoma are diagnosed with an aggressive form of the disease that has already spread.
FDA’s approval was based on a , called ZUMA-2, that tested brexucabtagene in 60 patients with mantle cell lymphoma who had received up to five prior treatments. "
(20min delay)